Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea.

Liu A, Abbasi F, Kim SH, Ariel D, Lamendola C, Cardell J, Xu S, Patel S, Tomasso V, Mojaddidi H, Grove K, Tsao PS, Kushida CA, Reaven GM.

Am J Cardiol. 2017 Apr 15;119(8):1205-1210. doi: 10.1016/j.amjcard.2016.12.034. Epub 2017 Jan 25.

2.

Does enhanced insulin sensitivity improve sleep measures in patients with obstructive sleep apnea: a randomized, placebo-controlled pilot study.

Liu A, Kim SH, Ariel D, Abbasi F, Lamendola C, Cardell J, Xu S, Patel S, Tomasso V, Mojaddidi H, Grove K, Tsao PS, Kushida CA, Reaven GM.

Sleep Med. 2016 Jun;22:57-60. doi: 10.1016/j.sleep.2016.06.005. Epub 2016 Jun 21.

3.

Comparison of the association with sleep apnoea of obesity versus insulin resistance.

Liu A, Ariel D, Lamendola C, Kim SH, Abbasi F, Cardell J, Tomasso V, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Eur Respir J. 2015 Dec;46(6):1829-32. doi: 10.1183/13993003.01087-2015. Epub 2015 Sep 24. No abstract available.

4.

Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals.

Ariel D, Kim SH, Liu A, Abbasi F, Lamendola CA, Grove K, Tomasso V, Reaven GM.

J Clin Lipidol. 2015 Sep-Oct;9(5):658-63. doi: 10.1016/j.jacl.2015.06.009. Epub 2015 Jun 18.

5.

Usefulness of fetuin-A to predict risk for cardiovascular disease among patients with obstructive sleep apnea.

Liu A, Lamendola C, Ariel D, Abbasi F, Kim SH, Cardell J, Tomasso V, Xu S, Patel S, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Am J Cardiol. 2015 Jul 15;116(2):219-24. doi: 10.1016/j.amjcard.2015.04.014. Epub 2015 Apr 18.

6.

Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.

Liu A, Cardell J, Ariel D, Lamendola C, Abbasi F, Kim SH, Holmes TH, Tomasso V, Mojaddidi H, Grove K, Kushida CA, Reaven GM.

Sleep. 2015 May 1;38(5):793-9. doi: 10.5665/sleep.4678.

7.

Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study.

Kim SH, Liu A, Ariel D, Abbasi F, Lamendola C, Grove K, Tomasso V, Ochoa H, Reaven G.

Diabetes Care. 2014 Jul;37(7):1944-50. doi: 10.2337/dc13-2977.

8.

Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.

Kim SH, Liu A, Ariel D, Abbasi F, Lamendola C, Grove K, Tomasso V, Reaven G.

Diabetologia. 2014 Mar;57(3):455-62. doi: 10.1007/s00125-013-3134-3. Epub 2013 Dec 11.

9.

Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.

Kim SH, Abbasi F, Lamendola C, Liu A, Ariel D, Schaaf P, Grove K, Tomasso V, Ochoa H, Liu YV, Chen YD, Reaven G.

Diabetes Care. 2013 Oct;36(10):3276-82. doi: 10.2337/dc13-0354. Epub 2013 Jul 8.

Supplemental Content

Loading ...
Support Center